Investor Presentaiton

Appendix Social Profile: Scoring Full Detail (Definitions) Theme Categories Environment Social Governance Environmental Management Environmental Performance Climate Change Human Rights Reproductive Rights Stem Cell Research Labor Diversity Sexual Orientation Board Accountability Definition Evaluates the attributes that describe the company's environmental disclosure and policies. The attributes are equally weighted in the evaluation. • More than 80 disclosure attributes, such as disclosure of energy use, water use, conservation programs, emissions, and environmental fines . More than 40 policy attributes, such as a company-level policy, LEED (Leadership in Energy & Environmental Design) building certification, supplier/vendor standards, and a commitment to regular auditing Compares company performance to peers' performance on environmental issues, including toxic chemical releases, chemical waste production, oil or chemical spills, and environmental fines (toxic emissions per revenue, toxic production waste per revenue, chemical or oil spills per revenue, environmental fines per revenue). Evaluates attributes that describe the climate change-related disclosure and policies of a company. The attributes are equally weighted in the evaluation. • More than 30 disclosure attributes, such as participation in the Carbon Disclosure Project (CDP) and disclosure of direct and indirect CO2 emissions • More than 30 policy attributes, such as purchase of carbon credits, independent verification of emissions credits obtained, and presence of quantifiable targets and goals Evaluates the company's human rights-related disclosure, policies, and management systems, and exposure to human rights issues and concerns. • . Abortifacients Production-Companies involved in the manufacture of pharmaceutical products designed to induce an abortion. Contraceptives Production-Companies involved in the manufacture of products designed to prevent pregnancy, which may include pharmaceutical and non-pharmaceutical products. Embryonic Stem Cell or Fetal Tissue Research: These ratings identify companies that conduct research involving human embryonic stem cells and/or fetal tissue, either directly or through proxy arrangements. Evaluates the relationship of a company to its workers and organized labor by looking at unionization rates, strikes, boycotts, disclosure, benefits, and Equal Employment Opportunity Commission (EEOC) findings. Evaluates the overall profile of a company on gender and minority issues. Elements include levels of disclosure and performance in manager diversity as well as total workforce diversity. Assesses corporate policies related to sexual orientation that may contribute to concerns regarding discrimination, as well as broader employer policies and best practices. Evaluates the level of responsibility and answerability of a company's board on climate change and environmental policies, human rights policy, codes of ethics, and ESG (environmental, social, and governance) risk management. Source: Institutional Shareholder Services, Inc. Details available upon request. aperio For Professional Investor Use Only 9

View entire presentation